XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating activities:    
Net loss $ (20,978) $ (85,348)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation 6,223 4,934
Depreciation 5,208 4,039
Debt related fees and amortization expense 4,732 5,199
Intangibles and other amortization expense 35 35
Accretion and other expenses of Series A preferred units 20,188 5,920
Loss on asset disposals 0 47
Loss (gain) on debt extinguishment 0 49,386
Warrants issued for working capital agreement 409 0
Gain on litigation 0 (1,400)
Loss on lease termination 0 736
Deferred tax expense (144) 0
Changes in operating assets and liabilities:    
Accounts receivable (3,344) (7,987)
Inventories (3,616) (5,639)
Prepaid expenses 2,379 2,786
Other assets (56,797) (505)
Accounts payable 4,728 12,801
Accrued interest expense and fees 18,483 8,754
Other liabilities 2,356 (10,065)
Net cash used in operating activities (20,138) (16,307)
Investing activities:    
Capital expenditures (18,595) (28,931)
Grant proceeds and other reimbursements received for capital expenditures 7,682 7,401
Net cash used in investing activities (10,913) (21,530)
Financing activities:    
Proceeds from borrowings 41,449 39,860
Repayments of borrowings (22,586) (16,191)
Lender debt renewal and waiver fee payments (1,681) (1,169)
Payments on finance leases (394) (314)
Proceeds from issuance of common stock 14,767 7,996
Proceeds from exercise of stock options 45 206
Net cash provided by financing activities 31,600 30,388
Effect of exchange rate changes on cash and cash equivalents 117 (51)
Net change in cash and cash equivalents for period 666 (7,500)
Cash and cash equivalents at beginning of period 6,999 7,751
Cash and cash equivalents at end of period 7,665 251
Supplemental disclosures of cash flow information, cash paid:    
Cash paid for interest 6,926 15,476
Income taxes paid 20 10
Supplemental disclosures of cash flow information, non-cash transactions:    
Subordinated debt extension fees added to debt 680 680
Debt fees added to revolving lines 2,236 800
Fair value of warrants issued to subordinated debt holders 1,278 1,939
Fair value of stock issued to a related party for guarantee fees 0 2,012
Fair value of warrants issued to lender for debt issuance costs 245 3,158
Fair value of stock issued to lender 0 1,335
Lender debt extension, waiver, and other fees added to debt 384 583
Cumulative capital expenditures in accounts payable, including net increase of $474 and $1,535, respectively 13,459 15,957
Payment of debt added to revolving lines 0 16,266
Financing lease liabilities arising from obtaining right of use assets 0 2,932
Capital expenditures purchased on financing $ 0 $ 290